Chief Executive Officer
Keith Elliston, PhD, is an experienced entrepreneur who also spent 12 years in big pharma with Merck and Bayer. He has been involved in founding over a dozen biotechnology companies, including Sequana Therapeutics, Structural Genomics, Spotfire, and Genstruct/Selventa, and was CSO of Gene Logic helping lead its IPO. His scientific expertise is focused on systems biology, neurodegeneration, and cancer.
